ID   NALM-33
AC   CVCL_5671
SY   NALM33
DR   Cosmic; 999746
DR   DSMZ; ACC-782
DR   DSMZCellDive; ACC-782
DR   Wikidata; Q54907415
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9680106;
RX   PubMed=10609789;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=10609789); ~48 hours (DSMZ=ACC-782).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-782
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 18,23
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5672 ! NALM-34
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=10609789; DOI=10.1080/10428199909169616;
RA   Matsuo, Yoshinobu
RA   Drexler, Hans Gunther
RA   Takeuchi, Makoto
RA   Orita, Kunzo
RT   "Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34,
RT   established from a patient with acute lymphoblastic leukemia.";
RL   Leuk. Lymphoma 35:513-526(1999).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo, Yoshinobu
RA   Drexler, Hans Gunther
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//